Transcend Capital Advisors, LLC Moderna, Inc. Transaction History

Transcend Capital Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 17, 2022	BUY	$118.07 - $194.18 $3,896 - $6,407	33 Added 1.52%	2,200 $260,000
Q2 2022 Jul 12, 2022	BUY	$117.13 - $176.59 $253,820 - $382,670	2,167 New	2,167 $310,000
Q1 2022 Apr 20, 2022	SELL	$126.46 - $235.05 $595,120 - $1.11 Million	-4,706 Closed	0 $0
Q4 2021 Jan 20, 2022	BUY	$225.82 - $368.51 $74,068 - $120,871	328 Added 7.49%	4,706 $1.2 Million
Q3 2021 Nov 04, 2021	BUY	$221.9 - $484.47 $971,478 - $2.12 Million	4,378 New	4,378 $1.51 Million

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Transcend Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Transcend Capital Advisors, LLC with notifications on news.